NCT03217331View on ClinicalTrials.gov

CRD-102 for Right Heart Failure in Patients With Left Ventricular Assist Devices

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 6, 2018

Primary Completion Date

October 10, 2018

Study Completion Date

May 30, 2019

Conditions
Right Heart FailureLeft Ventricular Assist Device
Interventions
DRUG

CRD-102

14 mg CRD-102 capsules administered twice daily orally for 14 days.

Trial Locations (1)

60637

The University of Chicago Medical Center, Chicago

All Listed Sponsors
lead

Cardiora Pty. Ltd.

INDUSTRY

NCT03217331 - CRD-102 for Right Heart Failure in Patients With Left Ventricular Assist Devices | Biotech Hunter | Biotech Hunter